Janneke Verloop
Impact in
- Oncology top 5%
- Cancer survivorship and care
- Cancer Risks and Factors
- COVID-19 and healthcare impacts
- Global Cancer Incidence and Screening
-
- Effects and risks of endocrine disrupting chemicals
Papers in
- Oncology 11
- Cancer survivorship and care 7
- Cancer Risks and Factors 3
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Flora E. van Leeuwen (6 shared papers)Matti A. Rookus (6 shared papers)Karin Van Der Kooy (1 shared paper)Helen Klip (1 shared paper)Jan D. van Gool (1 shared paper)Curt W. Burger (1 shared paper)Sabine Siesling (10 shared papers)Joke C. Korevaar (9 shared papers)
- Journals
- Breast Cancer Research and Treatment (4 papers)The Breast (3 papers)Annals of Oncology (2 papers)European Journal of Cancer (2 papers)The Lancet (1 paper)
- Partner nations
- NetherlandsUnited KingdomSweden
In The Last Decade
Janneke Verloop
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 59
- Oncology 291
- Health, Toxicology and Mutagenesis 119
- Cancer Research 102
- Urology 50
- Genetics 73
Countries citing papers authored by Janneke Verloop
This map shows the geographic impact of Janneke Verloop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janneke Verloop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janneke Verloop more than expected).
Fields of papers citing papers by Janneke Verloop
This network shows the impact of papers produced by Janneke Verloop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janneke Verloop. The network helps show where Janneke Verloop may publish in the future.
Co-authors
The 25 scholars most cited alongside Janneke Verloop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 248 | |
| 2 | 2000 | 172 | |
| 3 | 2010 | 87 | |
| 4 | 2021 | 78 | |
| 5 | 2016 | 73 | |
| 6 | 2016 | 69 | |
| 7 | 2021 | 62 | |
| 8 | 2019 | 58 | |
| 9 | 2022 | 54 | |
| 10 | 2021 | 44 | |
| 11 | 2021 | 38 | |
| 12 | 2019 | 33 | |
| 13 | 2020 | 17 | |
| 14 | 2017 | 16 | |
| 15 | 2020 | 16 | |
| 16 | 2022 | 14 | |
| 17 | 2000 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2016 | 7 | |
| 20 | 2022 | 7 |
About Janneke Verloop
Janneke Verloop is a scholar working on Oncology, Cancer Research, Health, Toxicology and Mutagenesis, Health Information Management and Epidemiology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer survivorship and care (7 papers), Effects and risks of endocrine disrupting chemicals (4 papers), Breast Cancer Treatment Studies (4 papers), Cancer Risks and Factors (3 papers), Cervical Cancer and HPV Research (2 papers), BRCA gene mutations in cancer (2 papers), Electronic Health Records Systems (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Oncology (291 citations), Health, Toxicology and Mutagenesis (119 citations), Cancer Research (102 citations), Urology (50 citations) and Genetics (73 citations). Janneke Verloop has collaborated with scholars based in Netherlands, United Kingdom and Sweden. Frequent co-authors include Flora E. van Leeuwen, Matti A. Rookus, Karin Van Der Kooy, Helen Klip, Jan D. van Gool, Curt W. Burger, Sabine Siesling, Joke C. Korevaar, Kelly M. de Ligt and Marianne J Heins. Their work appears in journals such as Breast Cancer Research and Treatment, The Breast, Annals of Oncology, European Journal of Cancer and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.